Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations.

Stuve, Olaf; Weideman, Rick A; McMahan, Danni M; Jacob, David A; Little, Bertis B

Stuve, Olaf; Weideman, Rick A; McMahan, Danni M; Jacob, David A; Little, Bertis B.

Afiliación

Stuve O; Department of Neurology and Neurotherapeutics, University of Texas, Southwestern Medical School, Neurology Section (111H), Dallas VA Medical Center, 4500 Lancaster Road, Dallas, TX 75216, USA.
Weideman RA; Pharmacy Service, Dallas VA Medical Center, Dallas, TX, USA.
McMahan DM; Pharmacy Service, Dallas VA Medical Center, Dallas, TX, USA.
Jacob DA; Pharmacy Service, Veterans Integrated Service Network 17, Arlington, TX, USA.
Little BB; School of Public Health and Information Sciences, University of Louisville, KY, USA.

Ther Adv Neurol Disord ; 13: 1756286420935676, 2020.

Article en En | MEDLINE | ID: mdl-32647537

Palabras clave

Alzheimer's disease; diclofenac; etodolac; naproxen

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Neurol Disord Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google